GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Share News (CSRT)

  • There is currently no data for CSRT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS SUMMARY: Consort Medical Rises On Takeover Offer

Mon, 18th Nov 2019 10:22

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.

----------

FTSE 100 - LOSERS

----------

Aviva, down 3.8%. The insurer said it has decided to retain its Singapore businesses. Aviva said the move follows a "thorough" review of options for the Singapore business, including seeking offers for the business. Earlier on Monday, Bloomberg reported that Japan's MS&AD Insurance Group Holdings and Canada's Manulife Financial Corp were vying to buy Aviva's assets in Singapore and Vietnam, with the sale process entering its final stage. Also on Monday, Aviva confirmed that its joint venture in China will be retained, given the scale of the market, "excellent" relationship with its partner China Oil & Food Corp and the high growth prospects. Looking ahead, Aviva said it is continuing to explore strategic options for its operations in Hong Kong, Vietnam and Indonesia, with its respective partners in each country.

----------

BT Group, down 1.1%. Barclays downgraded the telecommunications company to Underweight from Equal Weight.

----------

FTSE 250 - WINNERS

----------

Diploma, up 3.6%. The technical products supplier upped its final payout for financial 2019 after reporting a "strong double-digit growth in revenues and earnings". The company, which supplies seals, filters, specialised wiring and fastners, said its remains confident of making further progress in the current financial 2020 as moderately lower underlying growth will be offset by a strong contribution from acquisitions. The London-headquartered company posted a 15% rise in pretax profit for the year ended September 30 to GBP83.5 million from GBP72.7 million a year ago. Revenue increased 12% year-on-year to GBP544.7 million from GBP485.1 million, comprising 5% underlying revenue growth, a 5% contribution from acquisitions and a 2% currency benefit. Diploma recommended a 15% increase in its final dividend to 20.5 pence per share, with the total annual payout up 14% to 29.0p from 25.5p last year.

----------

FTSE 250 - LOSERS

----------

PureTech Health, down 6.5%. Shares in the healthcare firm continued to decline after its independent affiliate resTORbio on Friday announced disappointing data from a study evaluating the safety and efficacy of a treatment for clinically symptomatic respiratory illness. PureTech Health closed down 9.5% on Friday.

----------

OTHER MAIN MARKET AND AIM - WINNERS

----------

Consort Medical, up 43% at 1,040p. The pharmaceutical company said it has agreed to a GBP505 million acquisition offer from Swedish peer Recipharm. Under the offer, a unit of Recipharm will pay 1,010 pence in cash for each Consort share, representing a premium of 39% to Consort's closing stock price of 726p on Friday. The proposed deal implies an enterprise value of GBP627 million for Consort. Recipharm may reduce its acquisition consideration if any dividend or other distribution is made by the Hemel Hempstead-based company, Consort said. Recipharm expects the acquisition to close in the first quarter of 2020. Recipharm has received irrevocable undertakings to accept its offer from each of the Consort directors in respect of their own shareholdings of, in aggregate, 81,172 Consort shares representing 0.2% of the outstanding share capital of Consort.

----------

Brady, up 41%. The risk management software provider said it has received an approach from a undisclosed potential offeror, which may result in a counterbid to GBP8.3 million offer made by private equity Hanover Investors Management. Brady, however, added there was no certainty that an offer would be made by the potential offeror and that talks with the undisclosed party remain at an early stage. The potential offeror has until December 9 to either make an offer for Brady, or walk away, in accordance with UK takeover rules. The company separately said that the Hanover merger offer has been extended to November 29 as Hanover has not received over 50% valid acceptances for its offer. At the end of Friday, Hanover had received valid acceptances in respect 1.4% of the issued share capital of Brady. In mid-October, Brady agreed to a 10 pence per share cash takeover offer made by a vehicle of Hanover Active Equity Fund, valuing the firm at GBP8.3 million.

----------

OTHER MAIN MARKET AND AIM - LOSERS

----------

Inspirit Energy, down 47% at 0.11p. The micro combined heat and power boilers maker said it has raised GBP300,000 through a share placing to repay debt and continue development of its products. The company said it has issued 250.0 million shares at a price of 0.12 pence each. The company explained that the proceeds will allow it to finalise the development of the new enhanced 6.4 kilowatts boiler and seek the associated accreditation with a view to producing a unit for batch trail production. Inspirit also said it plans to repay GBP31,000 debt through the issue of 25.8 million shares. These are in addition to 250.0 million shares being issued in the placing. Upon admission, the company will have 1.70 billion shares overall, it said.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2017 08:10

Consort Medical splutters as BAT stubs out Voke programme

(ShareCast News) - British American Tobacco has terminated an agreement with Consort Medical over the manufacture of nicotine inhalers for its Voke development programme. Consort, which said it was in "constructive dialogue" with BAT's Nicovations arm and product developer Kind Consumer over the fut

Read more
6 Dec 2016 08:18

Consort Medical posts good growth in first half

(ShareCast News) - Single source drug and delivery device company Consort Medical announced its interim results for the six months to 31 October on Tuesday. The London-listed firm said group revenue increased to £144.9m from £135.5m, representing underlying growth of 2.0% and reported growth of 6.9%

Read more
25 Nov 2016 09:07

Consort Medical appoints new CFO

(ShareCast News) - Consort Medical, a global provider of manufacturing solutions for drugs, announced that it has appointed Paul Hayes as group Finance Director of the Vitec Group. Hayes is taking over the position of chief financial officer from Richard Cotton as well joining the board as executive

Read more
27 Oct 2016 07:45

Consort Medical Welcomes Cimzia Autoclicks Launch On NHS

Read more
14 Oct 2016 12:23

Consort Medical's Bespak inks new agreement

(ShareCast News) - Consort medical, a global single source drug and Delivery device company (CDMO), has announced that its Bespak division has entered into an agreement with a biopharmaceutical company. Bespak manufactures drug delivery devices for pharmaceutical partner companies including respirat

Read more
19 Sep 2016 09:07

Consort Notes European Nod For Bespak Technology-Using Product

Read more
7 Sep 2016 08:43

Consort Medical signs agreement with AstraZeneca

(ShareCast News) - Consort medical, a provider of advanced technology for drugs, has signed a new contract with pharmaceutical giant AstraZeneca for the supply of its Bespak respiratory devices. AstraZeneca and Bespak have agreed to enter into a multi-year agreement for the scale-up and supply of Be

Read more
7 Sep 2016 07:03

Consort Medical Sees Little Brexit Impact; Signs Deal With AstraZeneca

Read more
23 Jun 2016 15:19

Director dealings: Derwent London CEO sells just ahead of Brexit vote

(ShareCast News) - Derwent London chief executive John Burns has sold £1.5m of the FTSE 250 real estate investor's shares in the week just before the EU referendum which could seriously lift or undermine the company's shares. In Wednesday's sale, which comes two days before results for Britain's ref

Read more
17 Jun 2016 09:29

Numis places Consort Medical 'under review'

(ShareCast News) - Consort Medical's shares were put 'under review' by Numis after the company reported its full year results. The pharmaceutical device frim on Thursday reported full year earnings before interest and tax rose 47.6% to £37m as revenues gained 49.8% to £276.9m, driven by a strong per

Read more
16 Jun 2016 14:52

Consort Medical's annual revenues rise as a product launch is delayed

(ShareCast News) - Consort Medical, a pharmaceutical device company, revealed higher full year profits on Thursday due to organic growth and an acquisition. Revenues rose 49.8% to £276.9m from £184.8m the previous financial year. Bespak, the company's drug device manufacturing subsidiary, continued

Read more
16 Jun 2016 07:37

Consort Medical Profit Doubles As Progress Made On DEV610 Programme

Read more
9 Jun 2016 15:04

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
5 Apr 2016 08:32

BROKER RATINGS SUMMARY: Liberum Upgrades Babcock To Hold From Sell

Read more
22 Feb 2016 16:51

Consort Medical agrees partnership and invests in Precision Ocular

(ShareCast News) - Consort Medical has made a £3.3m equity investment for a 13.7% stake in retinal therapeutics specialist Precision Ocular and agreed a development and manufacturing partnership. London-based Precision Ocular has developed retinal treatments that are designed to access specific sma

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.